Network Meta-Analysis and Umbrella Review: Complementary, Not Competing, Tools of Evidence Synthesis

The increasing volume of randomized trials and systematic reviews in medical and allied fields has led to greater reliance on advanced evidence synthesis methods to inform clinical practice and policy. Network meta-analysis (NMA) and umbrella reviews (URs) are frequently placed at the apex of evidence hierarchies and are sometimes perceived as competing methodologies; however, they address fundamentally different objectives. NMA operates at the trial level, integrating direct and indirect comparisons across a connected network to generate comparative effect estimates and, where appropriate, treatment rankings, making it particularly suited for focused clinical questions involving multiple active interventions. In contrast, URs function at the review level, synthesizing and critically appraising existing systematic reviews and meta-analyses to provide a panoramic overview of a broad topic, highlighting consistency, discordance, methodological limitations, and evidence gaps rather than producing new pooled estimates. Neither approach is inherently superior; their evidentiary value depends on the clinical question, the quality and structure of the available evidence, and the intended application. Used appropriately, NMAs provide decision-grade quantitative comparisons, while URs offer strategic orientation and research prioritization. Viewed together, they represent complementary, not competing, tools that strengthen evidence-informed decision-making in clinical practice.